Dr Alexander Claus Viardot

Barell G; Balko K; Viardot A, 2013, 'Nutritional issues and their management in PWS', in Prader-Willi Syndrome, pp. 137 - 156

Brzozowska MM; Tran T; Bliuc D; Jorgensen J; Talbot M; Fenton-Lee D; Chen W; Hong A; Viardot A; White CP; Nguyen TV; Pocock N; Eisman JA; Baldock PA; Center JR, 2021, 'Roux-en-Y gastric bypass and gastric sleeve surgery result in long term bone loss', International Journal of Obesity, vol. 45, pp. 235 - 246, http://dx.doi.org/10.1038/s41366-020-00660-x

Viardot A; Purtell L; Nguyen TV; Campbell LV, 2018, 'Relative contributions of lean and fat mass to bone mineral density: Insight from Prader-Willi syndrome', Frontiers in Endocrinology, vol. 9, http://dx.doi.org/10.3389/fendo.2018.00480

Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, vol. 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5

Brooks L; Viardot A; Tsakmaki A; Stolarczyk E; Howard JK; Cani PD; Everard A; Sleeth ML; Psichas A; Anastasovskaj J; Bell JD; Bell-Anderson K; Mackay CR; Ghatei MA; Bloom SR; Frost G; Bewick GA, 2017, 'Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety', Molecular Metabolism, vol. 6, pp. 48 - 60, http://dx.doi.org/10.1016/j.molmet.2016.10.011

Viardot A, 2017, 'The value of the sulfonylurea gliclazide compared to newer oral antidiabetic agents', Therapeutische Umschau, vol. 74, pp. 423 - 431, http://dx.doi.org/10.1024/0040-5930/a000936

Polyviou T; MacDougall K; Chambers ES; Viardot A; Psichas A; Jawaid S; Harris HC; Edwards CA; Simpson L; Murphy KG; Zac-Varghese SEK; Blundell JE; Dhillo WS; Bloom SR; Frost GS; Preston T; Tedford MC; Morrison DJ, 2016, 'Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon', Alimentary Pharmacology and Therapeutics, vol. 44, pp. 662 - 672, http://dx.doi.org/10.1111/apt.13749

Purtell L; Viardot A; Campbell LV, 2016, 'Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndrome', Endocrine, vol. 53, pp. 619 - 620, http://dx.doi.org/10.1007/s12020-016-0889-6

Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford C; Finlayson GS; Blundell JE; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Gibson GR; Kolida S; Dhillo WS; Bloom SR; Morley W; Clegg S; Frost G, 2015, 'Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults', Gut, vol. 64, pp. 1744 - 1754, http://dx.doi.org/10.1136/gutjnl-2014-307913

Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV, 2015, 'Postprandial metabolism in adults with prader-willi syndrome', Obesity, vol. 23, pp. 1159 - 1165, http://dx.doi.org/10.1002/oby.21041

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2015, 'Effects of elevating colonic propionate on liver fat content in overweight adults with non-alcoholic fatty liver disease: a pilot study', Proceedings of the Nutrition Society, vol. 74, http://dx.doi.org/10.1017/s0029665115000452

Chambers E; Viardot A; Psichas A; Morrison D; Murphy K; Zac‐Varghese S; Preston T; Tedford C; Bell J; Thomas L; Dhillo W; Bloom S; Frost G, 2015, 'Effects of Elevating Colonic Propionate on Liver Fat Content in Adults with Non‐Alcoholic Fatty Liver Disease', The FASEB Journal, vol. 29, http://dx.doi.org/10.1096/fasebj.29.1_supplement.385.2

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2014, 'Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults', Proceedings of the Nutrition Society, vol. 73, http://dx.doi.org/10.1017/s0029665114000366

Frost G; Sleeth ML; Sahuri-Arisoylu M; Lizarbe B; Cerdan S; Brody L; Anastasovska J; Ghourab S; Hankir M; Zhang S; Carling D; Swann JR; Gibson G; Viardot A; Morrison D; Thomas EL; Bell JD, 2014, 'The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism', Nature Communications, vol. 5, http://dx.doi.org/10.1038/ncomms4611

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Finlayson G; Blundell JE; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2014, 'Targeted delivery of propionate to the colon stimulates the release of anorectic gut hormones and suppresses appetite in humans', Proceedings of the Nutrition Society, vol. 73, http://dx.doi.org/10.1017/s0029665114000299

Samaras K; Botelho NK; Jenkins A; Lord RV; Viardot A, 2013, 'Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery', Diabetologia, vol. 56, pp. 2564 - 2572, http://dx.doi.org/10.1007/s00125-013-3033-7

Tan TM; Field BCT; McCullough KA; Troke RC; Chambers ES; Salem V; Maffe JG; Baynes KCR; De Silva A; Viardot A; Alsafi A; Frost GS; Ghatei MA; Bloom SR, 2013, 'Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia', Diabetes, vol. 62, pp. 1131 - 1138, http://dx.doi.org/10.2337/db12-0797

Samaras K; Viardot AC; Lee PL; Jenkins AJ; Botelho NK; Bakopanos A; Lord RV; Hayward CS, 2013, 'Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: The role of immune cell activation and insulin resistance', Diabetes and Vascular Disease Research, vol. 10, pp. 40 - 48, http://dx.doi.org/10.1177/1479164112443375

Purtell L; Herzog H; Sainsbury A; Smith A; Loughnan G; Steinbeck KS; Campbell LV; Sze L; Viardot A, 2013, 'Postprandial cardiac autonomic function in Prader-Willi syndrome', Clinical Endocrinology, vol. 79, pp. 128 - 133, http://dx.doi.org/10.1111/cen.12084

Viardot A; Heilbronn LK; Samocha-Bonet D; Mackay F; Campbell LV; Samaras K, 2012, 'Obesity is associated with activated and insulin resistant immune cells', Diabetes/metabolism research and reviews, vol. 28, pp. 447 - 454, http://dx.doi.org/10.1002/dmrr.2302

Purtell L; Sze L; Loughnan GT; Smith EM; Herzog H; Sainsbury-Salis A; Steinbeck KS; Campbell LV; Viardot A, 2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, vol. 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001

Chambers E; Guess N; Viardot A; Frost G, 2011, 'Dietary starch and fiber: potential benefits to body weight and glucose metabolism', Diabetes Management, vol. 1, pp. 521 - 528, http://dx.doi.org/10.2217/dmt.11.40

Viardot A; Lord RV; Samaras K, 2010, 'The Effects of Weight Loss and Gastric Banding on the Innate and Adaptive Immune System in Type 2 Diabetes and Prediabetes', Endocrinology, vol. 151, pp. 2396 - 2396, http://dx.doi.org/10.1210/endo.151.5.9992

Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A, 2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, vol. 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013

Viardot AC; Heilbronn L; Herzog H; Gregersen S; Campbell LV, 2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, vol. 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24

Viardot AC; Grey S; Mackay F; Chisholm DJ, 2007, 'Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype', Endocrinology, vol. 148, pp. 346 - 353, http://dx.doi.org/10.1210/en.2006-0686

Viardot A; Huber P; Puder JJ; Zulewski H; Keller U; Müller B, 2005, 'Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test', Journal of Clinical Endocrinology and Metabolism, vol. 90, pp. 5730 - 5736, http://dx.doi.org/10.1210/jc.2004-2264

Viardot A; Müller B, 2003, 'Dizziness and arterial hypertension in a younger patient: A 42-year-old self-employed heating engineer', Praxis, vol. 92, pp. 821 - 822, http://dx.doi.org/10.1024/0369-8394.92.17.821

Viardot A; Müller B, 2003, 'Vertigo and arterial hypertension in younger patients. Hyperaldosteronism (Conn syndrome) in diastolic arterial hypertension, chronic hypokalemia, right adrenal gland adenoma', Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, vol. 92, pp. 821 - 822

Barell G; Balko K; Viardot A, 2013, 'Nutritional issues and their management in PWS', in Prader-Willi Syndrome, pp. 137 - 156

Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV, 2016, Postprandial Metabolism in Adults with Prader-Willi Syndrome (vol 23, pg 1159, 2015), WILEY-BLACKWELL, United States, http://dx.doi.org/10.1002/oby.21594, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388275100029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Viardot AC; Samocha-Bonet D; Greenfield JR; Campbell LV; Heilbronn L, 2008, 'Experimental weight gain in humans induces insulin resistance in absence of systemic or adipose tissue inflammation', in Diabetologia, Springer, New York, NY, USA, pp. 164 - 165, presented at Diabetologia

Brzozowska MM; Tran T; Bliuc D; Jorgensen J; Talbot M; Fenton-Lee D; Chen W; Hong A; Viardot A; White CP; Nguyen TV; Pocock N; Eisman JA; Baldock PA; Center JR, 2021, 'Roux-en-Y gastric bypass and gastric sleeve surgery result in long term bone loss', International Journal of Obesity, vol. 45, pp. 235 - 246, http://dx.doi.org/10.1038/s41366-020-00660-x

Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, vol. 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5

Viardot A; Purtell L; Nguyen TV; Campbell LV, 2018, 'Relative contributions of lean and fat mass to bone mineral density: Insight from Prader-Willi syndrome', Frontiers in Endocrinology, vol. 9, http://dx.doi.org/10.3389/fendo.2018.00480

Viardot A, 2017, 'The value of the sulfonylurea gliclazide compared to newer oral antidiabetic agents', Therapeutische Umschau, vol. 74, pp. 423 - 431, http://dx.doi.org/10.1024/0040-5930/a000936

Brooks L; Viardot A; Tsakmaki A; Stolarczyk E; Howard JK; Cani PD; Everard A; Sleeth ML; Psichas A; Anastasovskaj J; Bell JD; Bell-Anderson K; Mackay CR; Ghatei MA; Bloom SR; Frost G; Bewick GA, 2017, 'Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety', Molecular Metabolism, vol. 6, pp. 48 - 60, http://dx.doi.org/10.1016/j.molmet.2016.10.011

Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y

Purtell L; Viardot A; Campbell LV, 2016, 'Vitamin D levels in primary growth hormone deficiency disorder Prader–Willi syndrome', Endocrine, vol. 53, pp. 619 - 620, http://dx.doi.org/10.1007/s12020-016-0889-6

Polyviou T; MacDougall K; Chambers ES; Viardot A; Psichas A; Jawaid S; Harris HC; Edwards CA; Simpson L; Murphy KG; Zac-Varghese SEK; Blundell JE; Dhillo WS; Bloom SR; Frost GS; Preston T; Tedford MC; Morrison DJ, 2016, 'Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon', Alimentary Pharmacology and Therapeutics, vol. 44, pp. 662 - 672, http://dx.doi.org/10.1111/apt.13749

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford C; Finlayson GS; Blundell JE; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Gibson GR; Kolida S; Dhillo WS; Bloom SR; Morley W; Clegg S; Frost G, 2015, 'Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults', Gut, vol. 64, pp. 1744 - 1754, http://dx.doi.org/10.1136/gutjnl-2014-307913

Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV, 2015, 'Postprandial metabolism in adults with prader-willi syndrome', Obesity, vol. 23, pp. 1159 - 1165, http://dx.doi.org/10.1002/oby.21041

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2015, 'Effects of elevating colonic propionate on liver fat content in overweight adults with non-alcoholic fatty liver disease: a pilot study', Proceedings of the Nutrition Society, vol. 74, http://dx.doi.org/10.1017/s0029665115000452

Chambers E; Viardot A; Psichas A; Morrison D; Murphy K; Zac‐Varghese S; Preston T; Tedford C; Bell J; Thomas L; Dhillo W; Bloom S; Frost G, 2015, 'Effects of Elevating Colonic Propionate on Liver Fat Content in Adults with Non‐Alcoholic Fatty Liver Disease', The FASEB Journal, vol. 29, http://dx.doi.org/10.1096/fasebj.29.1_supplement.385.2

Frost G; Sleeth ML; Sahuri-Arisoylu M; Lizarbe B; Cerdan S; Brody L; Anastasovska J; Ghourab S; Hankir M; Zhang S; Carling D; Swann JR; Gibson G; Viardot A; Morrison D; Thomas EL; Bell JD, 2014, 'The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism', Nature Communications, vol. 5, http://dx.doi.org/10.1038/ncomms4611

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Finlayson G; Blundell JE; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2014, 'Targeted delivery of propionate to the colon stimulates the release of anorectic gut hormones and suppresses appetite in humans', Proceedings of the Nutrition Society, vol. 73, http://dx.doi.org/10.1017/s0029665114000299

Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SEK; MacDougall K; Preston T; Tedford MC; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Dhillo WS; Bloom SR; Morley WG; Clegg S; Frost G, 2014, 'Targeted delivery of propionate to the human colon prevents body weight and intra-abdominal adipose tissue gain in overweight adults', Proceedings of the Nutrition Society, vol. 73, http://dx.doi.org/10.1017/s0029665114000366

Tan TM; Field BCT; McCullough KA; Troke RC; Chambers ES; Salem V; Maffe JG; Baynes KCR; De Silva A; Viardot A; Alsafi A; Frost GS; Ghatei MA; Bloom SR, 2013, 'Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia', Diabetes, vol. 62, pp. 1131 - 1138, http://dx.doi.org/10.2337/db12-0797

Samaras K; Botelho NK; Jenkins A; Lord RV; Viardot A, 2013, 'Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery', Diabetologia, vol. 56, pp. 2564 - 2572, http://dx.doi.org/10.1007/s00125-013-3033-7

Purtell L; Herzog H; Sainsbury A; Smith A; Loughnan G; Steinbeck KS; Campbell LV; Sze L; Viardot A, 2013, 'Postprandial cardiac autonomic function in Prader-Willi syndrome', Clinical Endocrinology, vol. 79, pp. 128 - 133, http://dx.doi.org/10.1111/cen.12084

Samaras K; Viardot AC; Lee PL; Jenkins AJ; Botelho NK; Bakopanos A; Lord RV; Hayward CS, 2013, 'Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: The role of immune cell activation and insulin resistance', Diabetes and Vascular Disease Research, vol. 10, pp. 40 - 48, http://dx.doi.org/10.1177/1479164112443375

Viardot A; Heilbronn LK; Samocha-Bonet D; Mackay F; Campbell LV; Samaras K, 2012, 'Obesity is associated with activated and insulin resistant immune cells', Diabetes/metabolism research and reviews, vol. 28, pp. 447 - 454, http://dx.doi.org/10.1002/dmrr.2302

Purtell L; Sze L; Loughnan GT; Smith EM; Herzog H; Sainsbury-Salis A; Steinbeck KS; Campbell LV; Viardot A, 2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, vol. 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001

Chambers E; Guess N; Viardot A; Frost G, 2011, 'Dietary starch and fiber: potential benefits to body weight and glucose metabolism', Diabetes Management, vol. 1, pp. 521 - 528, http://dx.doi.org/10.2217/dmt.11.40

Viardot A; Lord RV; Samaras K, 2010, 'The Effects of Weight Loss and Gastric Banding on the Innate and Adaptive Immune System in Type 2 Diabetes and Prediabetes', Endocrinology, vol. 151, pp. 2396 - 2396, http://dx.doi.org/10.1210/endo.151.5.9992

Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A, 2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, vol. 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013

Viardot AC; Heilbronn L; Herzog H; Gregersen S; Campbell LV, 2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, vol. 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24

Viardot AC; Grey S; Mackay F; Chisholm DJ, 2007, 'Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype', Endocrinology, vol. 148, pp. 346 - 353, http://dx.doi.org/10.1210/en.2006-0686

Viardot A; Huber P; Puder JJ; Zulewski H; Keller U; Müller B, 2005, 'Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test', Journal of Clinical Endocrinology and Metabolism, vol. 90, pp. 5730 - 5736, http://dx.doi.org/10.1210/jc.2004-2264

Viardot A; Müller B, 2003, 'Vertigo and arterial hypertension in younger patients. Hyperaldosteronism (Conn syndrome) in diastolic arterial hypertension, chronic hypokalemia, right adrenal gland adenoma', Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, vol. 92, pp. 821 - 822

Viardot A; Müller B, 2003, 'Dizziness and arterial hypertension in a younger patient: A 42-year-old self-employed heating engineer', Praxis, vol. 92, pp. 821 - 822, http://dx.doi.org/10.1024/0369-8394.92.17.821